ADM Expands US Precision Fermentation Ingredient Supply Plans With OvoPro and Whey Alternatives

ADM used its 3 November 2026 third-quarter earnings call to elevate precision fermentation from a side project to a named growth pathway, highlighting egg-white, whey and pet-food proteins made on existing US fermentation assets. For buyers that source precision fermentation ingredient suppliers in the USA, the update is less a startup pitch than a signal that a major agricultural processor is packaging dextrose feedstock, idle fermenters and customer relationships into a commercial biomanufacturing offer.

Chair and CEO Juan Luciano told analysts that biology plus technology will drive food innovation at scale for decades, and that protein is one of the clearest near-term examples. He said ADM is already working with customers across several tracks: animal-free chicken and lamb alternatives for pet food; commercial-scale production of an egg-white ingredient alternative for bakery, protein bars and pasta; and, with an unnamed technology partner, a whey alternative intended to match the molecular profile of conventional whey with more consistent quality amid dairy-protein tightness.

Clinton, Iowa and The EVERY Company OvoPro line

The egg programme already has a named manufacturing partner. In July 2026 ADM and The EVERY Company announced commercial-scale production of EVERY’s OvoPro egg-white protein at ADM’s Clinton, Iowa, facility. OvoPro is positioned as a high-protein, clean-label ingredient for binding, gelling, foaming and whipping, with a claimed PDCAAS of 1.0. In August, Iowa economic-development disclosures showed ADM planning a US$55.5 million conversion of an underutilised 463,503-square-foot fermentation building at Clinton, adding separation, purification, drying and packaging capacity for proteins and enzymes, with state tax credits approved for a project expected to create 53 jobs.

That capital plan sits alongside the company’s argument that it can scale without greenfield plants. Luciano cited three advantages: commercial-scale dextrose supply, reuse of fermentation assets ADM already owns, and an integrated R&D, supply-chain and customer network. On the call he described precision fermentation as a cost today, with an ambition to reach profitability in two to three years and a more meaningful contribution for ADM between years five and ten — a planning horizon, not a product-level forecast.

What this means for US ingredient buyers

The November framing matters for procurement because it places a diversified US supplier next to specialist CDMO and startup capacity. Food Tech Insider has previously covered mid-scale bottlenecks such as Primient’s planned iPROOF facility in Decatur; ADM’s message is that large existing corn-wet-milling sites can absorb partner organisms when customer offtake supports finishing trains.

Limitations remain clear. ADM did not disclose separate revenue for precision fermentation, did not name the whey partner, and tied further finishing equipment to customer commitments. Buyers evaluating precision fermentation ingredient suppliers in the USA should treat the earnings commentary as a capacity and partnership roadmap: confirm Clinton timelines for OvoPro, request application and supply guarantees category by category, and compare cost and quality claims against both dairy and other fermentation-derived egg or whey alternatives already clearing US regulatory paths.